National Bank of Canada’s Albireo Pharma Inc ALBO Stock Holding History

National Bank of Canada’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-191	Closed	-$4.12K	–	2927
2022 Q4	$4.12K	Hold	191	–	–	﹤0.01%	2367
2022 Q3	$4K	Hold	191	–	–	﹤0.01%	2417
2022 Q2	$4K	Hold	191	–	–	﹤0.01%	2505
2022 Q1	$6K	Hold	191	–	–	﹤0.01%	2528
2021 Q4	$4K	Buy	+191	New	+$5.08K	﹤0.01%	2602

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

National Bank of Canada's ALBO Position: Q1 2023 in Review

National Bank of Canada sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 191 shares — an estimated $4.12K sold.

National Bank of Canada first reported a position in ALBO in Q4 2021 and held it in 5 quarters. The position peaked at $6K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

National Bank of Canada reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
National Bank of Canada sold 191 Albireo Pharma Inc shares in Q1 2023, an estimated $4.12K.
National Bank of Canada first reported a position in Albireo Pharma Inc in Q4 2021 and held it in 5 quarters.
National Bank of Canada's Albireo Pharma Inc position peaked at $6K in Q1 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.